Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;395(4):451-8.
doi: 10.1007/s00423-009-0494-8. Epub 2009 May 6.

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials

Affiliations

The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials

J Gaedcke et al. Langenbecks Arch Surg. 2010 Apr.

Abstract

Purpose: The prognosis of patients with pancreatic cancer remains poor, even after potentially curative R0 resection. This discrepancy may be due to the histopathological misclassification of R1 cases as curative resections (R0) in the past.

Materials and methods: To test this hypothesis, color coding of all resection margins and organ surfaces as part of a standardized histopathological workup was implemented and prospectively tested on 100 pancreatic head specimens.

Results: Thirty-five patients were excluded from the analysis owing to the pathohistological diagnosis; only pancreatic ductal adenocarcinoma, distal bile duct adenocarcinoma, and periampullary adenocarcinoma were included. Applying the International Union Against Cancer criteria, 32 cancer resections were classified R0 (49.2%), while 33 cases turned out to be R1 resections (50.8%). The mesopancreas was infiltrated in 22 of the 33 R1 resection specimens (66.6%). It proved to be the only site of tumor infiltration in 17 specimens (51.5%). Applying the Royal College of Pathologists' criteria, 46 resections were classified R1 (70.8%). As expected, the mesopancreas again was the most frequent site of noncurative resection (n = 27; 58.7%).

Conclusion: Using the intensified histopathological workup for pancreatic head cancer specimens resulted in an increased rate of R1 resections and the mesopancreas represents the primary site for positive resection margins. Such results are of relevance for patients' stratification in clinical trials.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ad Stained surfaces of pancreatic head resection specimen (black—ventral; white—dorsal; yellow—pancreatic RM; green—groove of superior mesenteric vein; red—mesopancreatic RM)
Fig. 2
Fig. 2
Section planes indicated at resection specimen (a). Individual slices (b) and magnification of one representative slice (c). AC indicates the adenocarcinoma, MP the mesopancreas
Fig. 3
Fig. 3
Intraoperative view before (left) and after resection of the mesopancreas (right). Small arrows point to the superior mesenteric artery; large arrow indicates the resection line; dashed line indicates dissection plane (left; SMV—superior mesenteric vein; SMA—superior mesenteric artery; PV—portal vein)

References

    1. Buchler MW, Kleeff J, Friess H. Surgical treatment of pancreatic cancer. J Am Coll Surg. 2007;205:S81–S86. doi: 10.1016/j.jamcollsurg.2007.06.332. - DOI - PubMed
    1. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Buchler MW. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651–1660. doi: 10.1245/s10434-008-9839-8. - DOI - PubMed
    1. Fortner JG. Regional resection of cancer of the pancreas: a new surgical approach. Surgery. 1973;73:307–320. - PubMed
    1. Gudjonsson B. Survival statistics gone awry: pancreatic cancer, a case in point. J Clin Gastroenterol. 2002;35:180–184. doi: 10.1097/00004836-200208000-00011. - DOI - PubMed
    1. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511–518. doi: 10.1016/j.gassur.2005.09.016. - DOI - PubMed